795.35
price up icon0.91%   7.16
after-market After Hours: 795.30 -0.05 -0.01%
loading

Lilly Eli Co Stock (LLY) Latest News

pulisher
06:20 AM

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy? - The Motley Fool

06:20 AM
pulisher
Nov 29, 2024

Eli Lilly & Co. stock outperforms competitors on strong trading day - MarketWatch

Nov 29, 2024
pulisher
Nov 29, 2024

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Nov 29, 2024
pulisher
Nov 27, 2024

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030 - 24/7 Wall St.

Nov 27, 2024
pulisher
Nov 26, 2024

Eli Lilly Stock Pops After Biden Proposes Medicare Cover Obesity Drugs. Is LLY Stock A Buy? - Investor's Business Daily

Nov 26, 2024
pulisher
Nov 26, 2024

Eli Lilly shares jump on two big updates and Jim Cramer is so here for it - CNBC

Nov 26, 2024
pulisher
Nov 26, 2024

Eli Lilly, Amazon lead market cap stock movers on Tuesday - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

Eli Lilly Stock Is Rising Tuesday: What's Going On? - Benzinga

Nov 26, 2024
pulisher
Nov 26, 2024

Eli Lilly & Co. (LLY) and Novo Nordisk (NVO) gain on Biden's GLP-1 proposal - StreetInsider.com

Nov 26, 2024
pulisher
Nov 23, 2024

Jim Cramer on Eli Lilly and Company (LLY): ‘It’s Valuable’ - Insider Monkey

Nov 23, 2024
pulisher
Nov 22, 2024

Eli Lilly Stock Price | LLY Stock Quote, News, and History - Markets Insider

Nov 22, 2024
pulisher
Nov 22, 2024

Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock - Yahoo Finance

Nov 22, 2024
pulisher
Nov 22, 2024

Healthcare Stocks Got Crushed After the Election—Is It Time to Buy? - Morningstar

Nov 22, 2024
pulisher
Nov 21, 2024

ELI LILLY AND COMPANY (LLY) - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs - Benzinga

Nov 21, 2024
pulisher
Nov 21, 2024

Kisunla From Eli Lilly - Pharmacy Times

Nov 21, 2024
pulisher
Nov 21, 2024

Is Now a Good Time to Buy the Dip in Eli Lilly Stock? - The Motley Fool

Nov 21, 2024
pulisher
Nov 21, 2024

Eli Lilly, Verge announce milestones in ALS collaboration - Yahoo Finance

Nov 21, 2024
pulisher
Nov 21, 2024

Eli Lilly Teams With Laekna For Innovative Obesity Treatment - Finimize

Nov 21, 2024
pulisher
Nov 20, 2024

Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’ - Insider Monkey

Nov 20, 2024
pulisher
Nov 20, 2024

China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug - Reuters

Nov 20, 2024
pulisher
Nov 20, 2024

Oceanside Unified takes on Eli Lilly and CVS Caremark in insulin pricing lawsuit - CBS News 8

Nov 20, 2024
pulisher
Nov 20, 2024

Eli Lilly and China-based biotech Laekna team on obesity drug - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Eli Lilly in pact with Chinese biotech for novel weight loss therapy - Seeking Alpha

Nov 20, 2024
pulisher
Nov 20, 2024

UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 20, 2024

UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on Wednesday - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity - BioSpace

Nov 20, 2024
pulisher
Nov 20, 2024

Lilly to develop ALS therapeutics against targets identified under Verge collaboration - BioWorld Online

Nov 20, 2024
pulisher
Nov 20, 2024

Is It Time to Sell Eli Lilly and Pfizer Stocks? - The Motley Fool

Nov 20, 2024
pulisher
Nov 20, 2024

The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Eli Lilly: Procter & Gamble CEO joins board - Marketscreener.com

Nov 20, 2024
pulisher
Nov 19, 2024

Eli Lilly and Company (LLY) Announces Board Changes: Jon Moeller Joins, Karen Walker Resigns - GuruFocus.com

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly & Co Appoints Procter & Gamble CEO to Board - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly appoints Jon Moeller to board of directors - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Lilly announces changes on board of directors - Investors | Eli Lilly and Company

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly & Co. stock rises Tuesday, still underperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly & Co. (LLY) Announces Board Changes - StreetInsider.com

Nov 19, 2024
pulisher
Nov 19, 2024

Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial - CNBC

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip? - Benzinga

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity Fund - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Lilly’s Lp(a) targeting candidate muvalaplin meets primary endpoint in Phase 2 trial - World Pharmaceutical Frontiers

Nov 19, 2024
pulisher
Nov 19, 2024

Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease - OutSourcing-Pharma.com

Nov 19, 2024
pulisher
Nov 19, 2024

Lilly pill cuts genetic form of cholesterol nearly 86% in study - Reuters.com

Nov 19, 2024
pulisher
Nov 18, 2024

Cramer's Lightning Round: Eli Lilly is a buy - NECN

Nov 18, 2024
pulisher
Nov 18, 2024

Lilly heart drug muvalaplin significantly reduces lipoprotein(a) levels - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

Medicaid fuels US coverage of Novo, Lilly weight-loss drugs - Reuters

Nov 18, 2024
drug_manufacturers_general NVO
$106.80
price up icon 0.63%
drug_manufacturers_general JNJ
$155.01
price down icon 0.25%
$182.93
price down icon 0.08%
drug_manufacturers_general MRK
$101.64
price down icon 1.44%
drug_manufacturers_general NVS
$105.77
price up icon 0.86%
Cap:     |  Volume (24h):